LLY |
Eli Lilly and Company |
0 |
7.40% |
|
|
|
|
|
N/A |
0.00% |
44.40% |
42.16% |
---|
VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
5.23% |
|
|
|
|
|
N/A |
0.00% |
35.91% |
45.64% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
5.01% |
|
|
|
|
|
N/A |
0.00% |
33.44% |
22.47% |
---|
BBIO |
BridgeBio Pharma, Inc. |
0 |
4.44% |
|
|
|
|
|
N/A |
0.00% |
64.17% |
24.99% |
---|
4519.T |
CHUGAI PHARMACEUTICAL CO., LTD. |
|
3.98% |
|
|
|
|
|
|
|
|
|
---|
ASND |
Ascendis Pharma A/S |
0 |
3.84% |
|
|
|
|
|
N/A |
0.00% |
66.94% |
49.82% |
---|
CRNX |
Crinetics Pharmaceuticals, Inc. |
0 |
3.82% |
|
|
|
|
|
N/A |
0.00% |
45.83% |
31.48% |
---|
AZN.L |
ASTRAZENECA PLC |
|
3.71% |
|
|
|
|
|
|
|
|
|
---|
NOVO-B.CO |
NOVO NORDISK A/S |
|
3.39% |
|
|
|
|
|
|
|
|
|
---|
CYTK |
Cytokinetics, Incorporated |
0 |
3.29% |
|
|
|
|
|
N/A |
0.00% |
79.89% |
34.47% |
---|
AMGN |
Amgen Inc. |
0 |
3.28% |
|
|
|
|
|
N/A |
0.00% |
27.10% |
20.21% |
---|
DXCM |
DexCom, Inc. |
0 |
3.04% |
|
|
|
|
|
N/A |
0.00% |
31.22% |
2.43% |
---|
MREO |
Mereo BioPharma Group plc |
0 |
2.96% |
|
|
|
|
|
N/A |
0.00% |
247.17% |
46.42% |
---|
BSX |
Boston Scientific Corporation |
0 |
2.73% |
|
|
|
|
|
N/A |
0.00% |
21.29% |
9.00% |
---|
MIRM |
Mirum Pharmaceuticals, Inc. |
0 |
2.56% |
|
|
|
|
|
N/A |
0.00% |
133.27% |
40.59% |
---|
IONS |
Ionis Pharmaceuticals, Inc. |
0 |
2.56% |
|
|
|
|
|
N/A |
0.00% |
46.53% |
42.27% |
---|
MASI |
Masimo Corporation |
0 |
2.40% |
|
|
|
|
|
N/A |
0.00% |
50.31% |
49.80% |
---|
EW |
Edwards Lifesciences Corporation |
0 |
2.40% |
|
|
|
|
|
N/A |
0.00% |
22.48% |
4.02% |
---|
MLYS |
Mineralys Therapeutics, Inc. |
0 |
2.18% |
|
|
|
|
|
N/A |
0.00% |
456.33% |
9.22% |
---|
PODD |
Insulet Corporation |
0 |
2.10% |
|
|
|
|
|
N/A |
0.00% |
47.34% |
38.83% |
---|
MDT |
Medtronic plc |
0 |
2.05% |
|
|
|
|
|
N/A |
0.00% |
23.49% |
27.97% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
1.99% |
|
|
|
|
|
N/A |
0.00% |
35.99% |
35.90% |
---|
GPCR |
Structure Therapeutics Inc. |
0 |
1.89% |
|
|
|
|
|
N/A |
0.00% |
121.07% |
52.35% |
---|
ARWR |
Arrowhead Pharmaceuticals, Inc. |
0 |
1.71% |
|
|
|
|
|
N/A |
0.00% |
75.44% |
34.69% |
---|
RARE |
Ultragenyx Pharmaceutical Inc. |
0 |
1.71% |
|
|
|
|
|
N/A |
0.00% |
57.42% |
15.18% |
---|
MDGL |
Madrigal Pharmaceuticals, Inc. |
0 |
1.66% |
|
|
|
|
|
N/A |
0.00% |
61.24% |
39.57% |
---|
RCKT |
Rocket Pharmaceuticals, Inc. |
0 |
1.57% |
|
|
|
|
|
N/A |
0.00% |
173.45% |
70.73% |
---|
WST |
West Pharmaceutical Services, Inc. |
0 |
1.56% |
|
|
|
|
|
N/A |
0.00% |
32.01% |
19.32% |
---|
NTLA |
Intellia Therapeutics, Inc. |
0 |
1.44% |
|
|
|
|
|
N/A |
0.00% |
92.06% |
42.42% |
---|
AKRO |
Akero Therapeutics, Inc. |
0 |
1.33% |
|
|
|
|
|
N/A |
0.00% |
73.12% |
19.29% |
---|
ZEAL.CO |
ZEALAND PHARMA A/S |
|
1.33% |
|
|
|
|
|
|
|
|
|
---|
NOVN.SW |
NOVARTIS AG |
|
1.31% |
|
|
|
|
|
|
|
|
|
---|
VKTX |
Viking Therapeutics, Inc. |
0 |
1.22% |
|
|
|
|
|
N/A |
0.00% |
121.82% |
74.64% |
---|
NARI |
INARI MEDICAL, INC. |
|
1.15% |
|
|
|
|
|
|
|
|
|
---|
INSM |
Insmed Incorporated |
0 |
1.09% |
|
|
|
|
|
N/A |
0.00% |
72.86% |
66.33% |
---|
EWTX |
Edgewise Therapeutics, Inc. |
0 |
0.93% |
|
|
|
|
|
N/A |
0.00% |
116.75% |
15.19% |
---|
GUBRA.CO |
GUBRA A/S |
|
0.92% |
|
|
|
|
|
|
|
|
|
---|
SLNO |
Soleno Therapeutics, Inc. |
0 |
0.87% |
|
|
|
|
|
N/A |
0.00% |
56.83% |
19.13% |
---|
KROS |
Keros Therapeutics, Inc. |
0 |
0.86% |
|
|
|
|
|
N/A |
0.00% |
1,024.91% |
41.50% |
---|
VERV |
Verve Therapeutics, Inc. |
0 |
0.79% |
|
|
|
|
|
N/A |
0.00% |
184.40% |
3.87% |
---|
SLN |
Silence Therapeutics plc |
0 |
0.75% |
|
|
|
|
|
N/A |
0.00% |
203.24% |
37.91% |
---|
TERN |
Terns Pharmaceuticals, Inc. |
0 |
0.68% |
|
|
|
|
|
N/A |
0.00% |
124.25% |
34.89% |
---|
CRBP |
Corbus Pharmaceuticals Holdings, Inc. |
0 |
0.43% |
|
|
|
|
|
N/A |
0.00% |
137.46% |
47.17% |
---|